SLPI and cholangiocarcinoma: Nevertheless, direct evaluation of SLPI-targeted interventions was beyond the scope of the present work, and future studies will be required to determine whether SLPI inhibition can be safely and effectively exploited for therapeutic benefit in cholangiocarcinoma.